niraparib,lenalidomide
glaxosmithkline,clovis
['prima,(-primar)', ' rev ', '$clvs', 'gsk', '$gsk']
some thoughts on $clvs #esmo2022 data: decent performance in the itt crowd, but overall still comparable/lesser than the prima data $gsk. worse in hrd+ than nira. i don't see this data changing clin practice or changing $clvs rev outlook. clock continues to tick on mahaffy.
10+ Yr. Pharma Vet (Oncology - Strategy and Analytics). Biotech Investor. Newly anon. Here to learn, discuss and share memez. Do your own DD. #Biotech #oncology